Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Royalty Pharma Lifts Elan Bid to $13.00 a Share Plus CVR

June 7 (Bloomberg) -- Royalty Pharma raised its offer for Elan Corp Plc to $13.00 a share plus a contingent value right of as much as $2.50 a share, the company said today.

The offer, previously at $12.50 per share, potentially values each Elan share at up to $15.50 if additional CVR payment events occur, according to the statement.

To contact the reporter on this story: Makiko Kitamura in London at mkitamura1@bloomberg.net

To contact the editor responsible for this story: Jacqueline Simmons at jackiem@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.